Valuation check: VAPO's profit margin is -76.74%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2024
Trailing 12 months ending Jun 2024
Vapotherm (VAPO) currently reports a profit margin of -76.74% as of June 2024. That compares with -122.04% in the prior-year period — up 37.1% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Vapotherm's profit margin history and peer comparisons.
Vapotherm's profit margin increased from -122.04% to -76.74% — a 37.1% year-over-year increase (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Vapotherm's profit margin of -76.74% is lower than the Healthcare sector average of 13.89%. That is roughly 652.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Vapotherm's current -76.74% should be judged against Healthcare norms (sector average: 13.89%) and against VAPO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -76.74%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Vapotherm, and consider following VAPO for alerts when major investors trade the stock.